CTOs on the Move

Medical Concepts Development

www.medconceptsdev.com

 
MCD is a quality, solution oriented manufacturer of adhesive coated films, pouches, tapes, and special purpose products. MCD is ISO 13485:1996 Certified. Operating from it's GMP compliant Woodbury, Minnesota facility, MCD develops, markets, and
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Wound Healing Solutions

Wound Healing Solutions provides high quality, accessible and research driven wound management services to the patient`s bedside. Serving the long-term care and assisted living communities of New Jersey, Pennsylvania, Delaware, Maryland, Virginia and New York- our wound certified nurse practitioners provide socially responsible wound management.

Zeus Scientific, Inc.

Zeus Scientific, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

EXAKT Technologies

EXAKT Technologies is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BSN Medical Inc

BSN medical is a global medical device company specializing in the areas of Orthopaedics which focuses on bandaging, cast tapes, Plaster of Paris, splinting systems, orthopaedic soft goods, fracture bracing, and thermoplastics, Phlebology which serves

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.